Lexicon Pharmaceuticals LXRX
$ 0.72
-0.33%
Quarterly report 2024-Q3
added 11-13-2024
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Lonnel Coats |
Employees in the company |
184 |
Shares |
221 M |
Market Cap[1] |
$ 159 M |
EBITDA (LTM) |
$ -123 M |
P/E (LTM) |
-1.43 |
P/S (LTM) |
51.4 |
EPS (LTM) |
-0.76 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.